[EN] ANILINE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS [FR] DERIVES D'ANILINE UTILISES COMME MODULATEURS DU RECEPTEUR SELECTIF DE L'ANDROGENE
This invention relates to non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.
ANILINE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS
申请人:Turnbull Philip Stewart
公开号:US20090163588A1
公开(公告)日:2009-06-25
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.
ANILINE DERIVATIVED ANDROGEN-, GLUCOCORTICOID-, MINERALCORTICOID- AND PROGESTERONE- RECEPTOR MODULATORS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1654221A2
公开(公告)日:2006-05-10
PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-BETA PROTEIN ACCUMULATION
申请人:Motonaga Kozo
公开号:US20100222434A1
公开(公告)日:2010-09-02
The present invention provides: a pharmaceutical composition for inhibiting amyloid-β protein accumulation comprising a compound of the formula (I) or a pharmaceutically acceptable salt thereof; a method for inhibiting amyloid-β protein accumulation, comprising a step of administering an effective amount of the compound of the formula (I) or a pharmaceutically acceptable salt thereof to a mammal which may be diagnosed with an amyloid-β protein-related disease; and so on.